Gabapentin 800 MG Oral Tablet — RxCUI 310434
RxNorm drug concept · Semantic clinical drug
RxCUI 310434
Semantic clinical drug · SCD
● Current RxNorm concept 134 FDA products
400 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI310434
Official nameGabapentin 800 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped134
Package NDCs mapped400
Reported Medicaid activity (SDUD)3,153,612 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Gabapentin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Gabapentin is mainly used for two things: managing nerve pain that lingers after a shingles infection (called postherpetic neuralgia) in adults, and helping control partial onset s...
- This is a really important question. Taking gabapentin together with opioids like morphine, hydrocodone, or oxycodone significantly raises the risk of serious breathing problems —...
- Can I take gabapentin with my opioid pain medication?
- The most common ones — especially in the first few weeks — are dizziness, drowsiness, and sometimes loss of balance or coordination. Swelling in the feet or hands is also fairly co...
🕸️ Concept Web — How Gabapentin 800 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Gabapentin 800 MG Oral Tablet
RxCUI 310434 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Gabapentin
25480IN
-
Gabapentin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Neurontin
196498BN
-
Neurontin
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Gabapentin Oral Tablet
378099SCDF -
Gabapentin Oral Product
1156681SCDG -
Gabapentin Pill
1156682SCDG -
Gabapentin Oral Tablet [Neurontin]
368227SBDF -
Neurontin Oral Product
1182285SBDG -
Neurontin Pill
1182286SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Gabapentin Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Gabapentin 800 MG
346146SCDC -
Gabapentin 800 MG Oral Tablet [Neurontin]
261281SBD -
Gabapentin 800 MG [Neurontin]
574508SBDC
-
Gabapentin 800 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Gabapentin 800 MG
SCDC · 346146 -
Gabapentin Oral Tablet
SCDF · 378099 -
Gabapentin Oral Product
SCDG · 1156681 -
Gabapentin Pill
SCDG · 1156682
Brand-Name Concepts
-
Gabapentin 800 MG Oral Tablet [Neurontin]
SBD · 261281 -
Gabapentin 800 MG [Neurontin]
SBDC · 574508 -
Gabapentin Oral Tablet [Neurontin]
SBDF · 368227 -
Neurontin Oral Product
SBDG · 1182285 -
Neurontin Pill
SBDG · 1182286 -
Neurontin
BN · 196498
📦 FDA Products & Package NDCs
134 products · 400 package NDCs
400 package NDCs map to RxCUI 310434 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 76282-0707-90 | 90 TABLET in 1 BOTTLE (76282-707-90) | GABAPENTIN | Exelan Pharmaceuticals, Inc. | 2021-10-01 |
| 76420-0497-01 | 100 TABLET in 1 BOTTLE (76420-497-01) | Gabapentin | Asclemed USA, Inc. | 2022-10-10 |
| 76420-0497-05 | 500 TABLET in 1 BOTTLE (76420-497-05) | Gabapentin | Asclemed USA, Inc. | 2022-10-10 |
| 76420-0497-12 | 120 TABLET in 1 BOTTLE (76420-497-12) | Gabapentin | Asclemed USA, Inc. | 2022-10-10 |
| 76420-0497-24 | 240 TABLET in 1 BOTTLE (76420-497-24) | Gabapentin | Asclemed USA, Inc. | 2022-10-10 |
| 76420-0497-30 | 30 TABLET in 1 BOTTLE (76420-497-30) | Gabapentin | Asclemed USA, Inc. | 2022-10-10 |
| 76420-0497-60 | 60 TABLET in 1 BOTTLE (76420-497-60) | Gabapentin | Asclemed USA, Inc. | 2022-10-10 |
| 76420-0497-90 | 90 TABLET in 1 BOTTLE (76420-497-90) | Gabapentin | Asclemed USA, Inc. | 2022-10-10 |
| 76420-0836-01 | 100 TABLET in 1 BOTTLE (76420-836-01) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0836-05 | 500 TABLET in 1 BOTTLE (76420-836-05) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0836-12 | 120 TABLET in 1 BOTTLE (76420-836-12) | GABAPENTIN | Asclemed USA, Inc. | 2025-05-21 |
| 76420-0836-30 | 30 TABLET in 1 BOTTLE (76420-836-30) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0836-60 | 60 TABLET in 1 BOTTLE (76420-836-60) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0836-90 | 90 TABLET in 1 BOTTLE (76420-836-90) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0837-01 | 100 TABLET in 1 BOTTLE (76420-837-01) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0837-05 | 500 TABLET in 1 BOTTLE (76420-837-05) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0837-30 | 30 TABLET in 1 BOTTLE (76420-837-30) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0837-60 | 60 TABLET in 1 BOTTLE (76420-837-60) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 76420-0837-90 | 90 TABLET in 1 BOTTLE (76420-837-90) | GABAPENTIN | Asclemed USA, Inc. | 2024-08-07 |
| 77771-0177-05 | 500 TABLET in 1 BOTTLE (77771-177-05) | Gabapentin | Radha Pharmaceuticals, Inc. | 2023-11-03 |
| 77771-0177-90 | 90 TABLET in 1 BOTTLE (77771-177-90) | Gabapentin | Radha Pharmaceuticals, Inc. | 2023-11-03 |
| 77771-0178-05 | 500 TABLET in 1 BOTTLE (77771-178-05) | Gabapentin | Radha Pharmaceuticals, Inc. | 2023-11-03 |
| 77771-0178-90 | 90 TABLET in 1 BOTTLE (77771-178-90) | Gabapentin | Radha Pharmaceuticals, Inc. | 2023-11-03 |
| 80425-0035-01 | 30 TABLET in 1 BOTTLE (80425-0035-1) | Gabapentin | Advanced Rx of Tennessee, LLC | 2015-11-01 |
| 80425-0036-01 | 30 TABLET, FILM COATED in 1 BOTTLE (80425-0036-1) | Gabapentin | Advanced Rx of Tennessee, LLC | 2011-10-06 |
| 80425-0036-02 | 60 TABLET, FILM COATED in 1 BOTTLE (80425-0036-2) | Gabapentin | Advanced Rx of Tennessee, LLC | 2011-10-06 |
| 80425-0158-01 | 30 TABLET, FILM COATED in 1 BOTTLE (80425-0158-1) | Gabapentin | Advanced Rx Pharmacy of Tennessee, LLC | 2011-10-06 |
| 80425-0158-02 | 60 TABLET, FILM COATED in 1 BOTTLE (80425-0158-2) | Gabapentin | Advanced Rx Pharmacy of Tennessee, LLC | 2011-10-06 |
| 80425-0201-01 | 30 TABLET, COATED in 1 BOTTLE (80425-0201-1) | Gabapentin | Advanced Rx of Tennessee, LLC | 2022-10-28 |
| 80425-0201-02 | 60 TABLET, COATED in 1 BOTTLE (80425-0201-2) | Gabapentin | Advanced Rx of Tennessee, LLC | 2022-10-28 |
| 80425-0201-03 | 90 TABLET, COATED in 1 BOTTLE (80425-0201-3) | Gabapentin | Advanced Rx of Tennessee, LLC | 2022-10-28 |
| 80425-0201-04 | 120 TABLET, COATED in 1 BOTTLE (80425-0201-4) | Gabapentin | Advanced Rx of Tennessee, LLC | 2022-10-28 |
| 80425-0204-01 | 30 TABLET, COATED in 1 BOTTLE (80425-0204-1) | Gabapentin | Advanced Rx of Tennessee, LLC | 2023-11-01 |
| 80425-0204-02 | 60 TABLET, COATED in 1 BOTTLE (80425-0204-2) | Gabapentin | Advanced Rx of Tennessee, LLC | 2023-11-01 |
| 80425-0204-03 | 90 TABLET, COATED in 1 BOTTLE (80425-0204-3) | Gabapentin | Advanced Rx of Tennessee, LLC | 2023-11-01 |
| 80425-0204-04 | 120 TABLET, COATED in 1 BOTTLE (80425-0204-4) | Gabapentin | Advanced Rx of Tennessee, LLC | 2023-11-01 |
| 82009-0071-05 | 500 TABLET, FILM COATED in 1 BOTTLE (82009-071-05) | Gabapentin | QUALLENT PHARMACEUTICALS HEALTH LLC | 2023-09-01 |
| 82009-0072-05 | 500 TABLET, FILM COATED in 1 BOTTLE (82009-072-05) | Gabapentin | QUALLENT PHARMACEUTICALS HEALTH LLC | 2023-09-01 |
| 82619-0145-01 | 100 TABLET in 1 BOTTLE (82619-145-01) | Gabapentin | Creekwood Pharmaceuticals LLC | 2024-09-01 |
| 82619-0145-02 | 500 TABLET in 1 BOTTLE (82619-145-02) | Gabapentin | Creekwood Pharmaceuticals LLC | 2024-09-01 |
| 82619-0146-01 | 100 TABLET in 1 BOTTLE (82619-146-01) | Gabapentin | Creekwood Pharmaceuticals LLC | 2024-09-01 |
| 82619-0146-02 | 500 TABLET in 1 BOTTLE (82619-146-02) | Gabapentin | Creekwood Pharmaceuticals LLC | 2024-09-01 |
| 82804-0203-30 | 30 TABLET, COATED in 1 BOTTLE, PLASTIC (82804-203-30) | Gabapentin | Proficient Rx LP | 2025-03-19 |
| 82804-0203-60 | 60 TABLET, COATED in 1 BOTTLE, PLASTIC (82804-203-60) | Gabapentin | Proficient Rx LP | 2025-03-05 |
| 82804-0203-90 | 90 TABLET, COATED in 1 BOTTLE, PLASTIC (82804-203-90) | Gabapentin | Proficient Rx LP | 2025-03-05 |
| 82804-0249-90 | 90 TABLET in 1 BOTTLE (82804-249-90) | GABAPENTIN | Proficient Rx LP | 2025-10-16 |
| 83301-0001-01 | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (83301-0001-1) | Gabapentin | Mullan Pharmaceutical Inc. | 2024-01-01 |
| 83301-0001-02 | 500 TABLET, COATED in 1 BOTTLE, PLASTIC (83301-0001-2) | Gabapentin | Mullan Pharmaceutical Inc. | 2024-01-01 |
| 83301-0002-01 | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (83301-0002-1) | Gabapentin | Mullan Pharmaceutical Inc. | 2024-01-01 |
| 83301-0002-02 | 500 TABLET, COATED in 1 BOTTLE, PLASTIC (83301-0002-2) | Gabapentin | Mullan Pharmaceutical Inc. | 2024-01-01 |
Observed labelers:
Bryant Ranch Prepack (75) ·
Proficient Rx LP (41) ·
Laurus Labs Limited (30) ·
Aphena Pharma Solutions - Tennessee, LLC (21) ·
Asclemed USA, Inc. (18) ·
DIRECT RX (16)
· +43 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.